The offering overhang may pressure CYTK shares in the short term as the 11.3 million new shares enter the market. Monitor for price stabilization and any updates on use of proceeds. Historically, similar-sized offerings for biotechs can lead to 5-10% declines within a week.
CYTK drugs
CYTK drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 8 $76.91entry
- T+1 · 6mo ago −3.06%α −3.29% · $74.56
- T+5 · 6mo ago +2.25%α +0.79% · $78.64
- T+20 · 5mo ago −7.06%α −7.08% · $71.48
- T+60 · 3mo ago +2.21%α −2.63% · $78.61
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Cytokinetics closed an underwritten public offering of 11.3 million shares at $71.00 per share, raising approximately $805 million in gross proceeds. The offering represents dilution of about 8.7% of the pre-offering market capitalization, which may pressure the stock in the near term as the additional shares enter the market.
Key Financial Metrics
Key Facts
- Offering of 11,338,028 shares at $71.00 per share
- Gross proceeds of approximately $805 million
- Full exercise of underwriters' option to purchase additional shares
- Closing of offering announced on May 08, 2026
Financial Impact
Gross proceeds of $805 million, representing dilution of approximately 8.7% of pre-offering market capitalization
Risk Factors
- Dilutive effect of 8.7% increase in share count
- Potential short-term selling pressure from offering participants
- Uncertainty about use of proceeds
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3291210 |
Track record
46 reports on CYTK
6 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +8.59% at T+20 after the Sep 15, 2026 report. 9 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $53.76 Now $53.17 −1.10% settles Dec 15
- Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.13 Now $53.17 −5.27% settles Dec 14
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $56.18 Now $53.17 −5.36% settles Dec 9
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $56.18 Now $53.17 −5.36% settles Dec 9
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $55.14 Now $53.17 −3.57% settles Dec 8
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $55.14 Now $53.17 −3.57% settles Dec 8
- Nov 4, 202612d ago 8-K Bullish 6/10 No price data
- Nov 4, 202612d ago Press Release Neutral 5/10 Entry $55.55 Now $53.17 −4.28% settles Dec 4
- Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $63.60 Now $53.17 −16.40% settles Dec 3
- Nov 2, 202614d ago Press Release Neutral 3/10 Entry $62.03 Now $53.17 −14.28% settles Dec 1
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers